NDC00548-1192-00: LIDOCAINE HYDROCHLORIDE INJECTIO.
LIDOCAINE HYDROCHLORIDE INJECTIO. Key specifications include administration: INTRACARDIAL, special_features: EACH SYRINGE CONTAINS 50 MG. LIDOCAINE HYDROCHLORIDE; NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES; WITHOUT EPINEPHARINE IN, features_provided: STERILE, primary_container_type: SYRINGE-NEEDLE UNIT, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10.
This part is cataloged in the U.S. Government catalog under NSN 6505-01-284-0272, indicating validated use in U.S. government and defense logistics supply chains.
Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| administration | INTRACARDIAL |
| special_features | EACH SYRINGE CONTAINS 50 MG. LIDOCAINE HYDROCHLORIDE; NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES; WITHOUT EPINEPHARINE IN |
| features_provided | STERILE |
| primary_container_type | SYRINGE-NEEDLE UNIT |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 5.000 MILLILITERS |
| active_medicament_medicinal_strength | 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| NSN | 6505-01-284-0272 |
| ADMINISTRATION | INTRACARDIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | SYRINGE-NEEDLE UNIT |
| SPECIAL FEATURES | EACH SYRINGE CONTAINS 50 MG. LIDOCAINE HYDROCHLORIDE; NEEDLE SIZE 21 GAGE BY 1-1/2 INCHES; WITHOUT EPINEPHARINE IN |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
No substitute or cross-reference records for this part.